CAPTRUST Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$151K	Sell	15,887 -1,853	-10%	-$14.4K	﹤0.01%	2741
2025 Q4	$138K	Sell	17,740 -1,839	-9%	-$13.3K	﹤0.01%	2577
2025 Q3	$149K	Sell	19,579 -2,526	-11%	-$21K	﹤0.01%	2469
2025 Q2	$198K	Buy	22,105 +1,527	+7%	+$14.2K	﹤0.01%	2309
2025 Q1	$154K	Buy	20,578 +4,080	+25%	+$32.9K	﹤0.01%	2198
2024 Q4	$124K	Buy	16,498 +224	+1%	+$1.7K	﹤0.01%	2188
2024 Q3	$124K	Buy	16,274 +2,644	+19%	+$20.1K	﹤0.01%	2190
2024 Q2	$84.2K	Buy	13,630 +345	+3%	+$1.9K	﹤0.01%	2120
2024 Q1	$67.5K	Buy	+13,285	New	+$74.7K	﹤0.01%	2073
2022 Q3	–	Sell	-6,421	Closed	-$68K	–	2262
2022 Q2	$68K	Sell	6,421 -166	-3%	-$1.71K	﹤0.01%	2507
2022 Q1	$107K	Buy	6,587 +341	+5%	+$5.47K	﹤0.01%	2211
2021 Q4	$87K	Sell	6,246 -1,571	-20%	-$20.8K	﹤0.01%	2261
2021 Q3	$112K	Buy	7,817 +2,624	+51%	+$41.4K	﹤0.01%	1982
2021 Q2	$82K	Hold	5,193	–	–	﹤0.01%	2174
2021 Q1	$53K	Sell	5,193 -657	-11%	-$6.77K	﹤0.01%	2394
2020 Q4	$44K	Sell	5,850 -1,250	-18%	-$6.44K	﹤0.01%	1885
2020 Q3	$25K	Buy	7,100 +3,628	+104%	+$15.5K	﹤0.01%	1875
2020 Q2	$17K	Buy	+3,472	New	+$13.9K	﹤0.01%	2002